With nearly a decade of professional expertise, Gabriele excels as an enterprising figure and previously occupied a high-ranking position at The Economist. His career showcases extensive international involvement in the pharmaceutical and healthcare industries.

Driven by a fervent interest in innovation and life sciences, Gabriele has devoted close to ten years to creating a profound impact on the global pharmaceutical and healthcare landscapes. He has delivered invaluable assistance to numerous firms through his proficiency in a range of critical areas, including legal and regulatory compliance, commercial due diligence, risk assessment and business valuation, intellectual property negotiations, as well as addressing strategic planning and post-merger integration obstacles.

In addition, he contributes his insights as a Non-Executive Board Member
at CO.GE.SAS.R.L., a prominent Italian infrastructure firm. Under his guidance, the company has been recognised for its impressive economic growth, ranking among the top expanding companies in Italy from 2019 to 2022 in the 6th edition of the “Campioni della Crescita 2024” report by La Repubblica Newspaper and the German Institute for Quality and Finance. In this role, Gabriele has embraced advanced technologies such as Artificial Intelligence and Machine Learning to optimise operations and spearhead strategic commercial forecasting.

At PVS Partners, Gabriele provides a broad international perspective and demonstrates a steadfast dedication to excellence. These qualities establish him as a reputable pharmaceutical and management consulting authority.